---

$3.19

-0.4450 ( -14.61% ) 311.5K

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-06-04	Sale	-1248.00	Litchman Manuel MD
2024-06-04	Sale	-1396.00	Litchman Manuel MD
2024-01-03	Sale	-419092.00	Fortress Biotech, Inc.

Reset

Symbol	Issuer Name	Market Value ↓	Share Quantity
No records found.